Search by Drug Name or NDC
NDC 68788-7103-06 Diclofenac Sodium and Misoprostol 75; 200 mg/1; ug/1 Details
Diclofenac Sodium and Misoprostol 75; 200 mg/1; ug/1
Diclofenac Sodium and Misoprostol is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is DICLOFENAC SODIUM; MISOPROSTOL.
MedlinePlus Drug Summary
The combination of diclofenac and misoprostol is used to relieve the pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints) in patients who have a high risk of developing stomach ulcers. Diclofenac is in a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by stopping the body's production of a substance that causes pain and inflammation. Misoprostol is in a class of medications called prostaglandins. It prevents ulcers caused by diclofenac by protecting the stomach lining and decreasing stomach acid production.
Related Packages: 68788-7103-06Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Diclofenac and Misoprostol
Product Information
| NDC | 68788-7103 |
|---|---|
| Product ID | 68788-7103_70cdd102-b3a2-4576-9567-309ca4732305 |
| Associated GPIs | 66109902200630 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Diclofenac Sodium and Misoprostol |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Diclofenac Sodium and Misoprostol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 75; 200 |
| Active Ingredient Units | mg/1; ug/1 |
| Substance Name | DICLOFENAC SODIUM; MISOPROSTOL |
| Labeler Name | Preferred Pharmaceuticals Inc. |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Prostaglandin E1 Analog [EPC], Prostaglandins E, Synthetic [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203995 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68788-7103-06 (68788710306)
| NDC Package Code | 68788-7103-6 |
|---|---|
| Billing NDC | 68788710306 |
| Package | 6 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-7103-6) |
| Marketing Start Date | 2018-03-13 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |